Balyasny Asset Management LLC Seagen Inc. Transaction History

Balyasny Asset Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $303 Million - $342 Million	1,582,447 Added 227.29%	2,278,686 $483 Million
Q2 2023 Aug 14, 2023	BUY	$187.64 - $206.25 $71.1 Million - $78.1 Million	378,859 Added 119.37%	696,239 $134 Million
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $22.8 Million - $36.3 Million	178,881 Added 129.16%	317,380 $64.3 Million
Q4 2022 Feb 14, 2023	BUY	$117.37 - $139.17 $14 Million - $16.6 Million	119,437 Added 626.57%	138,499 $17.8 Million
Q3 2022 Nov 14, 2022	SELL	$135.27 - $180.11 $37.5 Million - $49.9 Million	-276,916 Reduced 93.56%	19,062 $2.61 Million
Q2 2022 Aug 15, 2022	BUY	$108.81 - $179.33 $15.4 Million - $25.4 Million	141,888 Added 92.08%	295,978 $52.4 Million
Q1 2022 May 16, 2022	BUY	$119.61 - $157.85 $929,130 - $1.23 Million	7,768 Added 5.31%	154,090 $22.2 Million
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $20.9 Million - $27.9 Million	146,322 New	146,322 $22.6 Million
Q3 2021 Nov 15, 2021	SELL	$142.45 - $169.82 $23.3 Million - $27.8 Million	-163,718 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$135.08 - $161.1 $7.06 Million - $8.42 Million	52,257 Added 46.88%	163,718 $25.8 Million
Q1 2021 May 17, 2021	BUY	$137.51 - $190.8 $13.3 Million - $18.4 Million	96,508 Added 645.41%	111,461 $15.5 Million
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $2.46 Million - $3.17 Million	14,953 New	14,953 $2.62 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.